Bioelectric Medicine Market Report 2026

Bioelectric Medicine Market Overview

• Bioelectric Medicine market size has reached to $26.81 billion in 2025 • Expected to grow to $39.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Rising Healthcare Expenditure Driving Bioelectric Medicine Market Growth • Market Trend: Advancements In Bioelectric Medicine Enhanced Deep Brain Stimulation Therapy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioelectric Medicine Market?

Bioelectric medicine, also known as electroceuticals or bioelectronic medicine, is a medical science field that focuses on using electrical signals to modulate the body's nervous system to treat various diseases and conditions. This approach involves devices that generate precise electrical impulses to influence nerve activity, restore normal function, and promote healing in targeted body areas. The main types of bioelectric medicine are implantable electroceutical devices, non-invasive electroceutical devices. Implantable electroceutical devices refer to devices inserted into the body to deliver therapeutic electrical stimulation for medical purposes. The products includes implantable cardioverter-defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators (tens), sacral nerve stimulators, vagus nerve stimulators, and others for applications such as arrhythmia, pain management, sensorineural hearing loss, parkinson’s disease, tremor, depression, treatment-resistant depression, and others used by end users includes hospitals, and others.

What Is The Bioelectric Medicine Market Growth Forecast?

The bioelectric medicine market size is expected to see strong growth in the next few years. It will grow to $39.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of minimally invasive treatment options, rising investments in electroceutical research, growing integration of digital health platforms, increasing focus on long-term disease management solutions. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of non-invasive electroceutical therapies, growing integration of AI-guided stimulation protocols, expansion of personalized bioelectric treatments, enhanced focus on chronic disease management.

What Is The Driver Of The Bioelectric Medicine Market?

The increasing healthcare expenditure is expected to propel the growth of the bioelectric medicine market going forward. Healthcare expenditure is the total amount of money spent on healthcare services and resources within a given time frame. The increase in healthcare expenditure is fueled by factors such as population aging, advancements in medical technology, and rising chronic disease prevalence. The increasing healthcare expenditure positively impacts bioelectric medicine by fostering greater investment in research, development, and adoption of innovative bioelectric therapies. For instance, in May 2024, according to the Office for National Statistics, a UK-based national statistical institute, in 2023, UK healthcare expenditure reached approximately $382.5 billion (£292 billion), up from $370.7 billion (£283 billion) in 2022. Therefore, the increasing healthcare expenditure will drive the bioelectric medicine industry going forward.

Key Players In The Global Bioelectric Medicine Market

Major companies operating in the bioelectric medicine market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Biotronik SE & Co KG, Cochlear Ltd, LivaNova PLC, Inspire Medical Systems Inc, Nevro Corporation, Axonics Inc, NeuroPace Inc, Zynex Inc, ElectroCore Inc, NeuroMetrix Inc, Soterix Medical Inc, Galvani Bioelectronics, MicroTransponder Inc, BioElectronics Corporation, Cerbomed GmbH, SetPoint Medical, Blackrock Neurotech, ONWARD Medical, Nalu Medical

Global Bioelectric Medicine Market Trends and Insights

Major companies operating in the bioelectric medicine market are focusing on technological advancements such as software-enabled general wellness bioelectric medicines to gain a competitive advantage. The software-enabled general wellness medicine gives users precise guidance for deep brain stimulation therapy procedures and aids in surgical planning, intraoperative electrode placement, and customized programming for deep brain stimulation therapy. For instance, in July 2023, Boston Scientific Corporation, a US-based bioelectric medicine and wellness company, announced that Vercise Neural Navigator 5 Software had received approval from the US FDA. This software provides advanced features for precise targeting and programming of deep brain stimulation (DBS) therapy. It integrates imaging data with stimulation parameters, allowing for tailored treatment of neurological disorders. This leads to accurate electrode placement, precise guidance in surgical planning, and customized programming, ultimately enhancing treatment outcomes and patient satisfaction.

What Are Latest Mergers And Acquisitions In The Bioelectric Medicine Market?

In May 2025, electroCore, Inc., a U.S.-based provider of noninvasive bioelectronic therapy and wellness devices, acquired NeuroMetrix, Inc., for US $4.49 per share in cash plus contingent value rights. With this acquisition, electroCore aims to expand its technology portfolio in noninvasive neuromodulation and accelerate market penetration in chronic pain and wellness segments. NeuroMetrix is a U.S.-based developer of wearable neurotechnology devices, offering the Quell platform for chronic pain management and DPNCheck diagnostics for peripheral neuropathy.

What Defines the Bioelectric Medicine Market?

The bioelectric medicine market consists of sales of peripheral nerve stimulation (PNS) devices, neuroprosthetics, functional electrical stimulation (FES) Devices, electroretinography (ERG) devices. This market includes electroceutical devices for wound healing, non-invasive brain stimulation devices, and wearable bioelectric monitoring devices. Values in this market represent the factory gate values, including the goods sold by manufacturers or creators to downstream entities or directly to end customers. It encapsulates the value of goods and related services offered by the creators of these medicinal devices.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioelectric Medicine Market Report 2026?

The bioelectric medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioelectric medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.